vision loss after hyperbaric oxygen therapy
Hi, I'm hoping I can get some direction on where to look for answers. My friend who is a type 1 diabetic had hyperbaric oxygen therapy to treat a foot wound a year ago. She completed the treatment in January 2019 and had significant decrease in her vision. She had Lasix years ago and now her vision is down to -4. Her wound doctor and eye doctor haven't been able to answer if her vision is now going to stay this way or if it will improve. Searching for articles hasn't been super helpful. They... vision loss after hyperbaric oxygen therapy
Conclusions: Overall, co-aggregation was more pronounced in monozygotic than in dizygotic twins, suggesting that disease overlap is largely attributable to genetic factors. Co-aggregation was common, and twins faced up to a ten-fold risk of developing diseases not present in their co-twin. Our results validate and refine previous heritability estimates based on smaller twin cohorts. PMID: 32229696 [PubMed - in process]
Publication date: Available online 1 April 2020Source: Canadian Journal of DiabetesAuthor(s): Selena Davis, Lee MacKay
ConclusionCCB with ACE or CCB with ARB combination strategies are equally acceptable in hypertensive Korean patients regarding the occurrence of NODM.
This article focuses on practical approaches and decision-making strategies for utilizing FCGM in primary care settings. PMID: 32223687 [PubMed - as supplied by publisher]
Review recommendations from a multi-institutional working group on the preoperative evaluation, monitoring, and postoperative management of pediatric patients with Type 1 diabetes.Anesthesia &Analgesia
Nutrition &Diabetes, Published online: 01 April 2020; doi:10.1038/s41387-020-0111-zAssociations between cognitive performance and Mediterranean dietary pattern in patients with type 1 or type 2 diabetes mellitus
This article aims for summarizing current clinical knowledge on screening, diagnosis, and treatment and gives an overview on the pathophysiology of exocrine pancreatic insufficiency in diabetes.Recent FindingsRecent studies reveal novel insights into the close interaction of acinar, ductal, and endocrine cells and the gut-pancreas axis.SummaryExocrine pancreatic insufficiency is a clinically relevant, frequent but poorly understood disorder in both type 1 and type 2 diabetes.
Conclusion: Thirty-minute scan durations and SUVR-1 provide quantitative outcome measures for 11C-(+)-PHNO, a dopamine D3 receptor–preferring agonist PET radioligand, to differentiate BCM in T1DM and HCs.
Publication date: April 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 3Author(s): Ilia Ostrovski, Leif E. Lovblom, Daniel Scarr, Alanna Weisman, Nancy Cardinez, Andrej Orszag, C. Marcelo Falappa, Émilie D'Aoust, Ahmad Haidar, Rémi Rabasa-Lhoret, Laurent Legault, Bruce A. Perkins
ConclusionsContinuous glucose monitoring device helped in the management of diabetes, although more research is needed to analyse the influence of other variables in the relations studied.